New study explains how systemic mastocytosis can affect the liver
The cellular changes that occur in the liver of patients with systemic mastocytosis (SM) have been described in a recent study.
The cellular changes that occur in the liver of patients with systemic mastocytosis (SM) have been described in a recent study.
A recent report describes a patient with undiagnosed systemic mastocytosis who experienced unexpected complications during heart surgery.
In a recent study, researchers found distinct plasma protein profiles show potential to refine indolent and advanced SM diagnoses.
Two cases involving patients with systemic mastocytosis (SM) without KIT mutations (KIT negative) have been recently reported.
Desensitization to isatuximab allergy in patients with ISM appears possible, according to a recent report.
A clinical trial assessing the efficacy of bezuclastinib in improving SM symptoms in patients with SM has shown positive mid-stage results.
A recent case report describes an asymptomatic patient with SM who was diagnosed after a routine colonoscopy.
A recently-published case report highlights the importance of adequate tissue sampling when evaluating for SM, researchers wrote.
New data shows over half of patients in a phase 2 study of an investigational SM therapy saw improvement in severe SM-associated symptoms.
Researchers of a recently-published study found autoantibodies to type I [IFN] do not affect the pathogenesis or manifestations of SM.